Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE:PBH) will release its fiscal 2026 fourth quarter and year-end earnings on Wednesday, May 13, 2026 after market close.
The company will host a conference call on Thursday, May 14, 2026 at 8:30 a.m. ET, available via live webcast on the Investor Relations page and by phone with prior registration; a replay will be posted for about one week.
Positive
- None.
Negative
- None.
News Market Reaction – PBH
In the Apr 30 session, PBH gained 0.54%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 20 | Strategic acquisition | Positive | +1.6% | Announced $1.045B Breathe Right and brands acquisition, seen as accretive. |
| Feb 05 | Earnings results | Negative | -2.2% | Q3 FY2026 revenue and EPS declined year over year with narrowed guidance. |
| Jan 12 | Earnings date set | Neutral | +1.8% | Announced Q3 FY2026 earnings release date and conference participation. |
| Nov 06 | Earnings results | Positive | +2.6% | Q2 FY2026 results ahead of outlook with raised EPS guidance and buybacks. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamental results and acquisition news often led to modest price gains, while softer earnings corresponded with a decline, suggesting generally aligned reactions to news quality.
Over the last several months, PBH has reported multiple earnings updates and executed strategic acquisitions. On Nov 6, 2025, Q2 FY2026 results with reaffirmed guidance and buybacks saw shares rise 2.56%. Q3 FY2026 results on Feb 5, 2026 showed revenue and EPS declines, with the stock down 2.21%. An earnings date announcement and conference participation on Jan 12, 2026 coincided with a 1.76% gain. The March 2026 Breathe Right acquisition agreement produced a 1.55% rise, underscoring constructive responses to strategic deals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close. The following morning, May 14, at 8:30 a.m. ET, the Company will host a conference call to discuss the results.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
